Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 19.37 USD 0.52%
Updated: May 23, 2024

Kiniksa Pharmaceuticals Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Income from Continuing Operations Peer Comparison

Comparables:

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Income from Continuing Operations
$8.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Income from Continuing Operations?
Income from Continuing Operations
8.6m USD

Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Income from Continuing Operations amounts to 8.6m USD.

What is Kiniksa Pharmaceuticals Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-96%

Over the last year, the Income from Continuing Operations growth was -96%.